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Do Moderate-Intensity and Vigorous-Intensity Physical Activities
Reduce Mortality Rates to the Same Extent?
Eric J. Shiroma, ScD; Howard D. Sesso, ScD, MPH; M. V. Moorthy, PhD; Julie E. Buring, ScD; I-Min Lee, MBBS, ScD
Background-—Limited data exist directly comparing the relative beneﬁts of moderate- and vigorous-intensity activities with all-
cause and cardiovascular (CV) disease mortality rates when controlling for physical activity volume.
Methods and Results-—We followed 7979 men (Harvard Alumni Health Study, 1988–2008) and 38 671 women (Women’s Health
Study, 1992–2012), assessing their physical activity and health habits through repeated questionnaires. Over a mean follow-up of
17.3 years in men and 16.4 years in women, there were 3551 deaths (1077 from CV disease) among men and 3170 deaths (620
from CV disease) among women. Those who met or exceeded an equivalent of the federal guidelines recommendation of at least
150 minutes of moderate-intensity activity, 75 minutes of vigorous-intensity activity, or a combination of the 2 that expended
similar energy experienced signiﬁcantly lower all-cause and CV disease–related mortality rates (men, 28% to 36% and 31% to 34%,
respectively; women: 38% to 55% and 22% to 44%, respectively). When comparing different combinations of moderate- and
vigorous-intensity activity and all-cause mortality rates, we observed sex-related differences. Holding constant the volume of
moderate- to vigorous-intensity physical activity, men experienced a modest additional beneﬁt when expending a greater
proportion of moderate- to vigorous-intensity physical activity in vigorous-intensity activities (Ptrend=0.04), but women did not
(Ptrend<0.001). Moderate- to vigorous-intensity physical activity composition was not associated with further cardiovascular
mortality rate reductions in either men or women.
Conclusions-—The present data support guidelines recommending 150 minutes of moderate-intensity activity per week,
75 minutes of vigorous-intensity activity per week, or an equivalent combination for mortality beneﬁts. Among men, but not
women, additional modest reductions in all-cause mortality rates are associated with a greater proportion of moderate- to vigorous-
intensity physical activity performed at a vigorous intensity. ( J Am Heart Assoc. 2014;3:e000802 doi: 10.1161/
JAHA.114.000802)
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T he 2008 US federal physical activity guidelinesrecommend at least 150 minutes per week of moder-
ate-intensity physical activity, 75 minutes per week of
vigorous-intensity physical activity, or an equivalent combi-
nation for health beneﬁts, including reduced mortality rates.1
Because either 150 minutes of moderate-intensity or 75 min-
utes of vigorous-intensity physical activity expends approxi-
mately the same energy, these guidelines imply that equal
total energy expenditure of moderate-intensity or vigorous-
intensity physical activity would confer similar health beneﬁts.
Data are limited regarding whether this assumption is
correct. In examining the scientiﬁc evidence to guide current
recommendations with regard to all-cause mortality, the US
federal Physical Activity Guidelines Advisory Committee
(www.health.gov/paguidelines) reviewed 11 studies that
provided information regarding physical activity intensity, of
which only 4 controlled for total volume of activity; the
committee concluded that for the same volume, higher-
intensity activities provide additional risk reduction.2 More
recent analyses, including a 2011 meta-analysis, have
yielded less consistent ﬁndings, with studies showing no
signiﬁcant additional beneﬁt from vigorous-intensity activity
or even a slight added beneﬁt in favor of moderate-intensity
activity.3–6 However, none of these studies directly com-
pared an equal volume of activities of moderate intensity,
vigorous intensity, or combinations of the 2 in relation to
mortality.4,7–9
Holding physical activity volume constant, we examined
whether the proportion of moderate- to vigorous-intensity
physical activity (MVPA) affects mortality rate reduction.
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Methods
Study Participants
We analyzed data from men in the Harvard Alumni Health
Study (HAHS) and women in the Women’s Health Study
(WHS). The HAHS is a prospective cohort study of men
matriculating at Harvard University between 1916 and 1950.
Men completed periodic health questionnaires beginning in
1962 on health habits and medical history. For this analysis,
12 805 men who returned a questionnaire in 1988 were
eligible. We chose 1988 as the baseline year so that the
period of study for men would be similar to that of women
described below. Men were excluded if they had missing
information on physical activity at baseline (n=591) or a
history of self-reported physician-diagnosed cardiovascular
disease (CVD), cancer, or diabetes before 1988 (n=4235).
This resulted in a ﬁnal baseline population of 7979 men. Men
provided written consent to participate, and the study was
approved by the institutional review board of the Harvard
School of Public Health.
The WHS is a completed randomized trial of aspirin and
vitamin E in the prevention of CVD and cancer, conducted
between 1992 and 2004 among 39 876 healthy women
initially aged ≥45 years.10–12 Women completed health
questionnaires every 6 months during the ﬁrst year and then
annually thereafter. Following the scheduled end of the trial,
women have been followed in an observational study. As with
the men, we excluded 1205 women with missing information
on physical activity at baseline or who had reported CVD,
cancer, or diabetes diagnoses occurring before baseline,
resulting in a ﬁnal baseline population of 38 671 women.
Women provided written consent to participate, and the study
was approved by the institutional review board of Brigham and
Women’s Hospital.
Assessment of Physical Activity
In the HAHS, for the baseline (in 1988) and 2 subsequent
physical activity questionnaires in 1993 and 1998, men
reported the number of ﬂights of stairs climbed daily and the
number of blocks walked daily and listed the frequency and
duration spent doing sports or recreational activities.13 The
HAHS questionnaire physical activity estimates had test-
retest correlation over 1 month of 0.72, the correlation
between questionnaire estimates and activity records was
0.65, and the correlation between questionnaires and doubly
labeled water was 0.67.14–16 Women reported their physical
activity using a similar questionnaire (ie, the same question-
naire as the HAHS but modiﬁed so that the data could be
coded more easily) at baseline, which was then updated every
2 to 3 years through 2008.13 The WHS questionnaire physical
activity estimates yielded a correlation of 0.79 when
compared with activity recalls and 0.62 when compared with
activity diaries over 4 past-week assessments. The WHS
questionnaire test-retest correlation over 2 years was 0.59.17
When compared with objective measures of physical activity,
vigorous-intensity activities were somewhat better reported
than moderate-intensity actvities.18
For each reported activity or group of activities, we
assigned a metabolic equivalent (MET) score, which repre-
sents the energy cost of the activity (or group of activities).19
Resting quietly requires 1 MET, and moderate-intensity
activities are deﬁned as activities requiring 3 to <6 METs,
whereas vigorous-intensity activities are those requiring 6
METs or more.20 Examples of moderate-intensity activities
include brisk walking, casual bicycling, and gardening,
whereas vigorous-intensity activities include jogging, lap
swimming, and playing tennis.
The volume of each reported activity or group of activities
was expressed as “MET-h/week,” calculated by multiplying the
MET score by the time spent per week (hours). We calculated 3
measures of physical activity volume for each subject: (1) total
physical activity volume, the sum across all activities; (2) mod-
erate-intensity volume, MET-h/week expended on activities of
moderate intensity, whichwas estimated by summing across all
activities in that intensity range; and (3) vigorous-intensity
volume, MET-h/week expended on activities of vigorous
intensity, which was estimated by summing across all activities
in that intensity range.
We classiﬁed men and women into 5 categories based on
the 2008 federal guidelines1 to reﬂect total physical activity
and to obtain reasonable distributions of subjects. The
following categories were used: (1) less than half the
recommended guideline (0 to <3.75 MET-h/week); (2) “some
activity” (3.75 to <7.5 MET-h/week); (3) satisfying the
guideline (7.5 to <15 MET-h/week); (4) 2 to <4 times the
guideline (15 to <30 MET-h/week); and (5) at least 4 times
the guideline (≥30 MET-h/week). The guidelines require that
activities be performed in bouts of at least 10 minutes;
however, we were unable to apply this requirement because
we did not ask about bout length.
To examine the composition of MVPA, we classiﬁed
participants into 5 categories of increasingly larger propor-
tions of MVPA spent on vigorous-intensity activities: 10% or
less, >10% to ≤25%, >25% to ≤50%, >50% to ≤75%, and >75%.
In analyses that control for the total volume of physical
activity, we compared participants with the same volume of
activity but comprising different proportions of moderate and
vigorous intensities.
Assessment of Baseline Covariates and Mortality
In men, baseline (1988) information was collected on age,
height, weight, smoking habits, and physician-diagnosed
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hypertension and high cholesterol. Dietary habits (including
alcohol consumption) were assessed using a semiquantitative
food questionnaire. All information, except diet, was updated
in 1993 and 1998. For women, baseline data included similar
information plus postmenopausal status, postmenopausal
hormone use, and parental history of myocardial infarction
before age 60 years. All information, except for diet, was
updated on the 36-, 72-, and 96-month questionnaires
during the trial, at trial conclusion (120 months), and in cycle
2 (144 months) and in cycle 4 (168 months) of observational
follow-up.
For men, mortality through 1997 was ascertained using
information from theHarvard University alumni ofﬁce to identify
decedents and to obtain copies of death certiﬁcates; this follow-
up is >99% complete.8 Between 1998 and 2008, mortality was
additionally ascertained using the National Death Index. For
women, family members or postal authorities reported most
deaths.Medical records and death certiﬁcateswere obtained to
conﬁrm these deaths. Other deaths were ascertained using the
National Death Index. Women were followed through March
2012, and mortality follow-up is >99% complete.
Statistical Analysis
Baseline characteristics of men and women were described by
categories of total physical activity. To examine the association
of mortality rates (all-cause and CVD) and increasing total
physical activity volume, hazard ratios (HRs) and 95% conﬁ-
dence intervals (CIs) were calculated comparing participants
with greater physical activity with those with the least, using
time-varying Cox proportional hazard models because physical
activity and covariates (except for diet) were updated over time.
We then compared categories of participants who
expended increasingly larger proportions of their MVPA on
vigorous-intensity activities with those in the referent cate-
gory, who spent ≤10%, controlling for total MVPA volume. A
statistically signiﬁcant HR of less than 1.0 indicates that a
larger proportion of MVPA at vigorous intensity is associated
with additional rate reduction compared with the referent.
For all analyses, we used 3 nested analytical models:
1. A model adjusted for age and total MVPA per week;
2. A multivariable model adjusted for age plus smoking
status; alcohol consumption; vegetable and fruit intake;
saturated fat intake; total caloric intake; and, in women
only, ﬁber intake, randomization arm of the clinical trial
period, parental history of myocardial infarction, postmen-
opausal status, and hormone therapy; and
3. A multivariable model additionally adjusted for body mass
index (kg/m2), high cholesterol, and hypertension.
We also examined whether the association of MVPA
composition and mortality differed by age (men, younger than
70 years or at least 70 years; women, less than 60 years or
at least 60 years). Multivariable adjusted models used a
complete case analysis. The proportional hazards assumption
was tested and found not to be violated (P>0.05).
Results
Baseline characteristics of the men (mean age=66.1 years
[SD=7.7 years]) and women (mean age=54.6 years [SD=7.0
years]) by total physical activity volume are in Table 1. Men
expended a median of 18.6 MET-h/week (25th percentile:
6.3; 75th percentile: 37.4) in physical activity; the median for
women was 8.4 MET-h/week (25th percentile: 2.7; 75th
percentile: 20.5). Of the 7979 men at baseline (year 1988),
3551 died (1077 of CVD) during 17.3 mean years of follow-up.
Of the 38 761 women at baseline (year 1992), 3170 died (620
of CVD) during 16.4 mean years of follow-up.
An inverse dose–response relationship of total physical
activity volume with mortality was observed in both men
and women after multivariable adjustment (Ptrend<0.001 for
both) (Figure 1). Men, who performed some activity,
expending 3.75 to less than 7.5 MET-h/week in total
physical activity, experienced a 19% reduction in mortality
rate (HR=0.81; 95% CI: 0.69 to 0.94) compared with the
least active men. In the most active men expending at least
30 MET-h/week in total physical activity (ie, ≥4 times the
guideline), we observed a 36% mortality rate reduction
(HR=0.64; 95% CI=0.57 to 0.72) compared with the least
active men. Women expending 3.75 to less than 7.5 MET-h/
week in total physical activity experienced a mortality rate
reduction of 26% (HR=0.74; 95% CI=0.66 to 0.83) compared
with the least active women. There was a 55% mortality rate
reduction (HR=0.45; 95% CI=0.40 to 0.52) in the most
active women compared with the least active women.
Additionally adjusting for body mass index, hypertension,
and high cholesterol (multivariable-adjusted model 2)
resulted in similar ﬁndings. Consequently, we chose to
report results from multivariable-adjusted model 1 because
body mass index, hypertension, and high cholesterol medi-
ate the inverse relationship between physical activity and
mortality rate.
A similar inverse dose–response relationship of total
physical activity volume and CVD mortality was observed in
both men and women (Figure 2). Men with at least some
activity experienced a 29% to 35% rate reduction compared
with the least active men (Ptrend=0.02), whereas correspond-
ing women experienced a rate reduction between 27% and
44% compared with the least active women (Ptrend<0.001)
(Figure 2).
At baseline, 36.2% of men performed 10% or less of MVPA
volume on vigorous-intensity activities, whereas 15.4%,
16.4%, 13.8%, and 18.2% respectively performed >10% to
DOI: 10.1161/JAHA.114.000802 Journal of the American Heart Association 3
Physical Activity Intensity and Mortality Shiroma et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
≤25%, >25% to ≤50%, >50% to ≤75%, and >75% of their MVPA
on vigorous-intensity activities. The median MVPA volume
varied across groups: Men with the lowest proportion of
vigorous-intensity volume expended 26.6 MET-h/week,
whereas those who performed >10% to ≤25%, >25% to
≤50%, >50% to ≤75%, and >75% of their MVPA on vigorous-
intensity activities respectively expended 12.0, 21.1, 26.5,
and 28.1 MET-h/week of MVPA.
A similar distribution was observed for the women:
30.6% of women performed 10% or less of their MVPA on
vigorous-intensity activities, whereas 13.7%, 17.1%, 15.1%,
and 23.6% respectively performed >10% to ≤25%, >25% to
≤50%, >50% to ≤75%, and >75% of their MVPA on vigorous-
intensity activities. Women with the lowest proportion of
vigorous-intensity volume expended 10.4 MET-h/week,
whereas those in the higher categories respectively
Table 1. Baseline Characteristics of Participants by Total Physical Activity Volume, Harvard Alumni Health Study (1988–2008)
and Women’s Health Study (1992–2012)
Characteristic
Total Physical Activity Volume (MET-h/week)*
<3.75 3.75 to <7.5 7.5 to <15 15 to <30 ≥30
(n=1327) (n=847) (n=1247) (n=1916) (n=2642)
Harvard Alumni Health Study (men)
Age, y, mean (SD) 68.5 (9.1) 66.5 (8.0) 65.6 (7.4) 65.2 (7.2) 66.0 (7.2)
BMI, kg/m2, mean (SD) 25.2 (3.6) 24.8 (3.2) 24.7 (2.9) 24.6 (2.8) 24.4 (2.7)
Current smoking, no. (%) 171 (13.0) 111 (13.2) 97 (7.8) 116 (6.1) 178 (6.8)
Daily alcohol intake, no. (%) 489 (37.2) 338 (40.0) 526 (42.4) 798 (41.8) 1184 (45.0)
Highest quartile of energy intake, no. (%) 252 (25.3) 181 (26.7) 243 (24.0) 372 (23.3) 554 (25.3)
Highest quartile of saturated fat, no. (%) 301 (30.3) 194 (28.7) 242 (23.9) 366 (22.9) 543 (24.8)
≥3 Servings/d of vegetables, no. (%) 179 (13.6) 106 (12.6) 147 (11.8) 292 (15.3) 399 (15.2)
≥3 Servings/d of fruits, no. (%) 106 (9.7) 59 (8.1) 105 (9.8) 198 (11.8) 271 (11.7)
Hypertension, no. (%) 391 (30.0) 232 (27.6) 349 (28.1) 472 (24.7) 639 (24.4)
High cholesterol, no. (%) 221 (16.9) 159 (19.0) 242 (19.5) 363 (19.1) 488 (18.7)
Total physical activity, MET-h/week, median (IQR) 1.2 (0.7 to 2.3) 5.2 (4.4 to 6.1) 11.3 (9.3 to 13.1) 21.6 (18.0 to 25.3) 49.5 (37.6 to 70.5)
Vigorous physical activity, MET-h/week, median (IQR) 0.7 (0.2 to 1.3) 1.2 (0.2 to 2.4) 2.0 (0.7 to 7.7) 7.2 (1.3 to 15.5) 18.8 (1.6 to 38.4)
Women’s Health Study (women) (n=11 941) (n=5763) (n=7569) (n=8291) (n=5107)
Age, y, mean (SD) 54.5 (7.0) 54.3 (6.9) 54.5 (6.9) 55.0 (7.2) 54.4 (7.0)
BMI, kg/m2, mean (SD) 27.3 (5.7) 26.0 (4.8) 25.7 (4.5) 25.0 (4.2) 24.4 (4.1)
Postmenopausal, no. (%) 6423 (16.6) 3035 (7.9) 4027 (10.4) 4591 (11.9) 2713 (7.0)
Current hormone replacement therapy, no. (%) 4615 (12.0) 2400 (6.2) 3211 (8.3) 3494 (9.1) 2203 (5.7)
Current smoking, no. (%) 2233 (5.8) 782 (2.0) 804 (2.1) 823 (2.1) 422 (1.1)
Parental history of MI, no. (%) 1774 (4.7) 755 (2.0) 1076 (2.8) 1147 (3.0) 724 (1.9)
Any alcohol intake, no. (%) 5756 (14.9) 3194 (8.3) 4384 (11.3) 4985 (12.9) 3194 (8.3)
Energy intake, kcal/d, mean (SD) 1690.1 (546.4) 1733.5 (531.6) 1730.8 (519.2) 1742.0 (522.6) 1767.7 (542.2)
Saturated fat, g/d, mean (SD) 20.6 (8.7) 20.1 (8.1) 19.5 (7.7) 19.1 (7.8) 18.2 (7.9)
Fiber intake, g/d, mean (SD) 16.7 (7.3) 18.5 (7.6) 19.3 (7.9) 20.1 (8.2) 22.0 (9.6)
Fruits and vegetables, servings/d, mean (SD) 5.2 (3.4) 5.9 (3.2) 6.2 (3.3) 6.6 (3.7) 7.5 (4.2)
Hypertension, no. (%) 3554 (9.2) 1472 (3.8) 1915 (5.0) 2005 (5.2) 1053 (2.7)
High cholesterol, no. (%) 3857 (10.0) 1732 (4.5) 2284 (5.9) 2415 (6.2) 1307 (3.4)
Total physical activity, MET-h/week, median (IQR) 1.3 (0.5 to 2.4) 5.4 (4.5 to 6.3) 10.3 (8.6 to 12.2) 20.9 (17.5 to 24.3) 42.5 (35.0 to 57.6)
Vigorous physical activity, MET-h/week, median (IQR) 0.2 (0.0 to 0.9) 0.9 (0.2 to 1.8) 1.5 (0.5 to 5.3) 5.1 (0.5 to 12.7) 23.0 (11.0 to 36.0)
BMI indicates body mass index; IQR, interquartile range; MET-h/week, metabolic equivalent score multiplied by the time spent per week (hours); MI, myocardial infarction.
*Total physical activity energy expenditure was calculated from walking, climbing stairs, and participating in leisure-time activities. Vigorous-intensity activities required at least 6 times the
metabolic rate.
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expended 7.2, 12.1, 16.4, and 1.6 MET-h/week of MVPA.
Of note, women with the highest percentage of MVPA in
vigorous-intensity activities actually had a low total volume
of MVPA (1.6 MET-h/week); they likely represented women
who did little activity but did climb stairs, a vigorous-
intensity activity.
Men with higher proportions of MVPA in vigorous-intensity
physical activity had modestly lower all-cause mortality rates
compared with the referent group for the same volume of
MVPA (P=0.04) (Figure 3). Compared with men who spent
10% or less of MVPA in vigorous-intensity activity, men with
>10% to ≤25% vigorous activity had an 8% (HR=0.92 [95% CI:
0.81 to 1.05]) lower mortality rate. Men who spent >25% to
≤50%, >50% to ≤75%, and >75% of their MVPA on vigorous-
intensity activities respectively had 10% (HR=0.90 [95% CI:
0.80 to 1.02]), 4% (HR=0.96 [95% CI: 0.83 to 1.09]), and 6%
(HR=0.94 [95% CI: 0.82 to 1.09]) lower mortality rates after
adjustment for total MVPA volume, smoking, and dietary
factors.
In contrast, we did not observe this phenomenon in women
(Figure 3). In adjusted models, compared with women with
the lowest proportion of MVPA in vigorous-intensity activities
(women with ≤10%), women with >10% to ≤25%, >25% to
≤50%, >50% to ≤75%, and >75% of their MVPA on vigorous-
intensity activities had HRs of 0.94 (95% CI: 0.82 to 1.08),
1.04 (95% CI: 0.91 to 1.18), 0.94 (95% CI: 0.80 to 1.09), and
1.23 (95% CI: 1.11 to 1.36), respectively.
When examining CVD mortality, neither men nor women
experienced any additional reduction in CVD mortality rate
when a greater proportion of MVPA volume was in
vigorous-intensity activity when total MVPA volume was held
constant (Pmen=0.19, Pwomen=0.29) (Figure 4). For both men
and women, the association of varying MVPA composition
with all-cause mortality rates did not differ by age (interaction:
Pmen=0.94, Pwomen=0.17) (Table 2). Similarly, no interaction of
MVPA composition and cardiovascular mortality rates was
observed by age (interaction: Pmen=0.53, Pwomen=0.58)
(Table 2).
Figure 1. Hazard ratio of all-cause mortality according to total physical activity volume, Harvard Alumni Health Study (1988–2008) and
Women’s Health Study (1992–2012). All values are hazard ratios (95% conﬁdence intervals) unless otherwise speciﬁed. aTotal physical activity
volume was calculated from walking, climbing stairs, and participating in leisure-time activities. bAdditionally adjusted for smoking status,
dietary factors, and alcohol consumption. cAdditionally adjusted for body mass index, high cholesterol, and hypertension. dAdditionally adjusted
for clinical trial randomization, smoking status, dietary factors, alcohol consumption, postmenopausal status, hormone therapy, and parental
history of myocardial infarction. Hazard ratios in ﬁgure were estimated using multivariable-adjusted model 1. MET indicates metabolic
equivalent.
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Discussion
In 2 parallel long-term prospective cohorts of older adults, we
observed an inverse association between total physical
activity volume and reductions in mortality among both men
and women. The most active persons experienced mortality
rates that were one third to one half lower compared with the
least active. Even smaller amounts of physical activity were
associated with lower mortality rates. These observations
support current guidelines, which acknowledge, “Some phys-
ical activity is better than none,” and recommending at least
150 minutes per week of at least moderate-intensity physical
activity such as brisk walking.1
When comparing MVPA regimens of similar total volume
but with varying proportions of moderate- and vigorous-
intensity physical activities, we found sex-related differences.
Men experienced a modest additional reduction of between
4% and 10% in all-cause mortality rates when their total MVPA
volume comprised greater proportions of vigorous-intensity
physical activities; however, women did not. In terms of CVD
mortality, neither men nor women beneﬁted further when a
higher proportion of their MVPA volume was from vigorous-
intensity physical activity.
Our ﬁndings in men support previous analyses of these
same men at younger ages (mean baseline ages of 467 and
58 years8), which showed that vigorous-intensity physical
activity further reduced the all-cause mortality rate but not the
CVD mortality rate compared with moderate-intensity physical
activity after controlling for total energy expenditure.7,8 These
analyses did not estimate the magnitude of further mortality
rate reductions, which were found to be modest (4% to 10%) in
the present study.
Among women, we found moderate-intensity physical
activity to be at least as beneﬁcial as vigorous-intensity
physical activity when MVPA volume was the same. Two
possible reasons might explain these ﬁndings in comparison
with men. First, the distribution of physical activity volume
differed between the 2 sexes, with men expending a larger
Figure 2. Hazard ratio of cardiovascular disease mortality according to total physical activity volume, Harvard Alumni Health Study (1988–
2008) and Women’s Health Study (1992–2012). All values are hazard ratios (95% conﬁdence intervals) unless otherwise speciﬁed. aTotal
physical activity volume was calculated from walking, climbing stairs, and participating in leisure-time activities. bAdditionally adjusted for
smoking status, dietary factors, and alcohol consumption. cAdditionally adjusted for body mass index, high cholesterol, and hypertension.
dAdditionally adjusted for clinical trial randomization, smoking status, dietary factors, alcohol consumption, postmenopausal status, hormone
therapy, and parental history of myocardial infarction. Hazard ratios in ﬁgure were estimated using multivariable-adjusted model 1. MET
indicates metabolic equivalent.
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volume of total and vigorous-intensity physical activity
compared with women. Women with the largest proportion
of MVPA volume spent on vigorous-intensity activities had a
median MVPA volume of only 1.6 MET-h/week, which was
substantially lower than the MVPA volume of women in the
other categories of MVPA composition. These women may
represent a higher risk group because overall physical activity
was associated with lower mortality rates. Thus, potential
residual confounding by diet and other healthy habits may
have occurred, even though we tried to control for these
statistically.
In addition, the results may reﬂect differences in dose–
response for physical activity intensity, depending on the
volume of physical activity expended. The present ﬁndings
suggest that intensity has a larger effect in men, at the higher
end of the physical activity spectrum, compared with women,
at the lower end of the spectrum. A previous meta-analysis of
physical ﬁtness reported that the dose–response curve with
all-cause morality was more marked at higher levels of ﬁtness
than at lower levels and that the dose response increased
with higher levels of ﬁtness.21 This could plausibly explain why
we observed no effect of intensity among women (at the lower
end of the curve) but an added effect of intensity among the
men (at the higher end of the curve).
Second, the ﬁndings in womenmay reﬂect lower precision in
the reporting of physical activities of differing intensities
compared with men. Walking accounted for the majority of
moderate-intensity physical activity (mean: 72% of MVPA) in
women, consistent with other studies. Walking is also more
precisely reported compared with other activities22,23; there-
fore, thismight also explain, in part, the observation that greater
additional beneﬁt was observed amongwomenwith the highest
proportion of MVPA in moderate-intensity physical activity.
Limited data exist comparing the mortality beneﬁts of
moderate- and vigorous-intensity physical activity energy
expenditure, particularly where total volume of physical
activity is controlled. Of the 4 studies reviewed by the US
Physical Activity Guidelines Advisory Committee,2 including
Figure 3. Hazard ratio of all-cause mortality according to percent of MVPA performed at vigorous intensity, Harvard Alumni Health Study
(1988–2008) and Women’s Health Study (1992–2012). All values are hazard ratios (95% conﬁdence intervals) unless otherwise speciﬁed. aTotal
physical activity volume was calculated from walking, climbing stairs, and participating in leisure-time activities. bAdditionally adjusted for
smoking status, dietary factors, and alcohol consumption. cAdditionally adjusted for body mass index, high cholesterol, and hypertension.
dAdditionally adjusted for clinical trial randomization, smoking status, dietary factors, alcohol consumption, postmenopausal status, hormone
therapy, and parental history of myocardial infarction. Hazard ratios in ﬁgure were estimated using multivariable-adjusted model 1. MVPA
indicates moderate- to vigorous-intensity physical activity.
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the 2 previous analyses of the HAHS men described above
and 1 in older men and women aged ≥65 years, all concluded
that vigorous-intensity physical activity may further reduce
mortality rates compared with moderate-intensity physical
activity of equivalent energy expenditure.7–9,24 More recent
studies are less consistent. A 2011 meta-analysis observed
that 75 minutes of vigorous-intensity activity and 150 min-
utes of moderate-intensity activities provided a similar
mortality rate reduction (11% for vigorous intensity and 10%
for moderate intensity), controlling for total physical activity
volume.4
Strengths of this study include the large sample of older
men and women in the HAHS and the WHS; multiple, detailed
assessments of physical activity; and nearly complete mor-
tality follow-up over >15 years, providing excellent statistical
power. Several limitations are also worth noting. Although
detailed, physical activity was self-reported. A recent
study comparing self-reported physical activity with acceler-
ometer-assessed physical activity found vigorous-intensity
physical activities to be somewhat better reported than
moderate-intensity activities (r=0.36 and 0.23, respec-
tively).18 In addition, these estimates of MVPA volume were
Table 2. Hazard Ratio of All-Cause and Cardiovascular Disease Mortality According to Percentage of MVPA Performed at Vigorous
Intensity by Age, Harvard Alumni Health Study (1988–2008) and Women’s Health Study (1992–2012)
No. of
Participants†
Percent of MVPA Performed at Vigorous Intensity*
P Value for
Trend
P Value for
Interaction≤10% >10% to ≤25% >25% to ≤50% >50% to ≤75% >75%
Harvard Alumni Health
Study (men)‡
All-cause mortality
Age, y
<70 5543 Reference 1.01 (0.84 to
1.21)
0.95 (0.80 to
1.12)
1.00 (0.83 to
1.19)
0.98 (0.80 to
1.19)
0.74 0.94
≥70 2436 Reference 0.85 (0.70 to
10.30)
0.86 (0.72 to
1.03)
0.90 (0.73 to
1.11)
0.94 (0.76 to
1.15)
0.008
Women’s Health Study
(women)§
Age, y
<60 30 428 Reference 0.89 (0.69 to
1.14)
0.98 (0.83 to
1.16)
1.05 (0.82 to
1.34)
1.33 (1.16 to
1.54)
<0.001 0.17
≥60 8243 Reference 1.07 (0.82 to
1.41)
1.07 (0.89 to
1.29)
0.84 (0.63 to
1.11)
1.13 (0.98 to
1.31)
0.20
Harvard Alumni Health
Study (men)‡
Cardiovascular disease mortality
Age, y
<70 5543 Reference 1.29 (0.92 to
1.79)
0.73 (0.50 to
1.05)
0.85 (0.59 to
1.24)
0.93 (0.63 to
1.39)
0.87 0.53
≥70 2436 Reference 0.88 (0.64 to
1.21)
0.74 (0.54 to
1.02)
0.69 (0.47 to
1.01)
0.77 (0.53 to
1.12)
0.18
Women’s Health Study
(women)§
Age, y
<60 30 428 Reference 0.52 (0.24 to
1.12)
0.97 (0.64 to
1.49)
1.00 (0.49 to
2.07)
0.90 (0.61 to
1.32)
0.86 0.58
≥60 8243 Reference 1.23 (0.68 to
2.20)
0.70 (0.44 to
1.10)
0.91 (0.50 to
1.66)
1.40 (1.04 to
1.87)
0.15
All values are hazard ratios (95% conﬁdence intervals) unless otherwise speciﬁed and represent additional associations, according to what percentage of MVPA is performed at vigorous
intensity. MVPA indicates moderate- to vigorous-intensity physical activity.
*Percentage of MVPA performed at vigorous intensity was calculated as the vigorous-intensity physical activity energy expenditure divided by total moderate- and vigorous-intensity
physical activity energy expenditure, estimated from walking, climbing stairs, and participating in leisure-time activities. Moderate-intensity activities required 3 to <6 times the metabolic
rate; vigorous-intensity activities required a metabolic equivalent score ≥6.
†Number of participants at baseline.
‡Hazard ratios are adjusted for age, MVPA, smoking status, dietary factors, and alcohol consumption.
§Hazard ratios are adjusted for age, MVPA, trial randomization, smoking status, dietary factors, alcohol consumption, postmenopausal status, hormone therapy, and parental history of
myocardial infarction.
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calculated using published MET values, which were estab-
lished using primarily middle-aged subjects, and reﬂect an
“absolute” intensity level, without taking into account “rela-
tive” intensity (ie, the same activity may require a higher
relative intensity in an older person than in younger person
because the older person’s physical capacity has declined
with age).19 This may result in misclassiﬁcation of moderate-
and vigorous-intensity physical activity.
Current guidelines also require that physical activity be
carried out in bouts of at least 10 minutes be to counted
toward the guidelines; however, we did not collect information
on bout length and so included all reported activities, regard-
less of bout length. Men in the HAHS and women in the WHS
are older adults, primarily white, of high education and
socioeconomic status—correlates of higher physical activity
levels—which may limit the generalizability of our ﬁndings.
In conclusion, the present data support federal physical
activity guidelines recommending at least 150 minutes of
moderate-intensity physical activity per week, 75 minutes of
vigorous-intensity physical activity per week, or a combina-
tion of the 2 for postponing premature mortality in older
adults. In translating these guidelines into clinical practice,
the focus is often on 150 minutes per week of moderate-
intensity physical activity25–28 because the US population is
typically inactive, and it is easier to initially promote this
lower intensity of activity, which would in turn lessen the
risk of musculoskeletal injury.2,29–32 Our ﬁndings indicate
that a focus on moderate-intensity physical activity is
appropriate in view of equivalent reductions in CVD mortality
in men and women and in all-cause mortality among
women.2,29–32 In men, additional modest reductions in all-
cause mortality rates were associated with a greater
proportion of MVPA volume performed at a vigorous
intensity. Future studies using objective measures of mod-
erate- and vigorous-intensity physical activity will be helpful
to add clarity.
Figure 4. Hazard ratio of cardiovascular disease mortality according to percent of MVPA performed at vigorous intensity, Harvard Alumni
Health Study (1988–2008) and Women’s Health Study (1992–2012). All values are hazard ratios (95% conﬁdence intervals) unless otherwise
speciﬁed. aTotal physical activity volume was calculated from walking, climbing stairs, and participating in leisure-time activities. bAdditionally
adjusted for smoking status, dietary factors, and alcohol consumption. cAdditionally adjusted for body mass index, high cholesterol, and
hypertension. dAdditionally adjusted for clinical trial randomization, smoking status, dietary factors, alcohol consumption, postmenopausal
status, hormone therapy, and parental history of myocardial infarction. Hazard ratios in ﬁgure were estimated using multivariable-adjusted
model 1. MVPA indicates moderate- to vigorous-intensity physical activity.
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